El investigador Alberto Ruano acude como invitado experto en radón al Congreso Mundial de Cáncer de Pulmón

El congreso se celebrará entre este sábado 6 y el martes 9 de agosto en Viena y acogerá en sus dos versiones, presencial y online, a asistentes de más de 100 países.

El proyecto ColoMARK del IDIS consigue más de 500.000€ en fondos de la UE Marie Sklodowska-Curie para el estudio del cáncer colorrectal

La investigadora del IDIS Ceres Fernández lidera el proyecto ColoMARK, desde 2019, para la identificación y desarrollo de nuevos biomarcadores en cáncer colorrectal mediante estrategias de biopsia líquida

Un equipo del IDIS descubre el motivo por el que la lactancia materna prolongada protege contra la obesidad en la adultez

El estudio, publicado en la revista Nature Metabolism determina el papel esencial de la proteína hepática FGF21 y su acción en la activación de la grasa parda, capaz de quemar calorías

News

Calendar

11 January 2022 January 11 - December 13
03 October 2022 October 3 - November 4
Load More

COMMON SUPPORT PLATFORMS

The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.

CALLS

All updated information on public and private competitive calls. The most convenient and safest way to send your requests.

CAREERS

Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.

Research Areas

ONCOLOGY

Improvement of treatments: personalised therapy and reduction of side effects.

GENETICS AND SYSTEMS BIOLOGY

Identification of genetic biomarkers of disease susceptibility and prognosis

ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO

The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.

NEUROSCIENCES

Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.

CARDIOVASCULAR

The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.

PLATFORMS AND METODOLOGY

The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.